Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.
A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.
The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.
With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.
Under the supervision of skillful managers and experts, business analysts produce reports that include:
- Product portfolio
- Potentially strong market reviews
- Competitive analytics
- Prospect partners
- Mergers and acquisitions project data
- Latest trends across a particular industry area
- Research and development strategies
- The analysis of new customers
- A set of remedial measures for projects
They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.
Publications found:
5,853
Sort by:
Pick Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Pick Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Pick Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provid...
May 2022
35 pages
Pituitary Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Pituitary Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Pituitary Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...
May 2022
35 pages
Plaque Psoriasis (Psoriasis Vulgaris) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,500.00
Plaque Psoriasis (Psoriasis Vulgaris) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Plaque Psoriasis (Psoriasis Vulgaris) Drugs in Development by Stages, Targ...
May 2022
159 pages
Plasma Cell Neoplasm Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Plasma Cell Neoplasm Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Plasma Cell Neoplasm Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Ke...
May 2022
40 pages
Pleomorphic Liposarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Pleomorphic Liposarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Pleomorphic Liposarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type...
May 2022
48 pages
Plexiform Neurofibroma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Plexiform Neurofibroma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Plexiform Neurofibroma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type an...
May 2022
37 pages
POEMS Syndrome (Crow-Fukase Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
POEMS Syndrome (Crow-Fukase Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY POEMS Syndrome (Crow-Fukase Syndrome) Drugs in Development by Stages, Targ...
May 2022
39 pages
Pol Polyprotein Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players
US$ 2,500.00
Pol Polyprotein Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Pol Polyprotein Drugs in Development by Therapy Areas and Indications, St...
May 2022
41 pages
Polymyositis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Polymyositis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Polymyositis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provid...
May 2022
38 pages
Polyomavirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Polyomavirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Polyomavirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type...
May 2022
57 pages
Post Operative Nausea And Vomiting Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Post Operative Nausea And Vomiting Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Post Operative Nausea And Vomiting Drugs in Development by Stages, Target, Mo...
May 2022
38 pages
Posterior Uveitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Posterior Uveitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Posterior Uveitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...
May 2022
45 pages
Postherpetic Neuralgia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Postherpetic Neuralgia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Postherpetic Neuralgia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type an...
May 2022
50 pages
Postoperative Ileus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Postoperative Ileus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Postoperative Ileus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key...
May 2022
36 pages
Pouchitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Pouchitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Pouchitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an...
May 2022
41 pages
Pre-Eclampsia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Pre-Eclampsia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Pre-Eclampsia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players prov...
May 2022
42 pages
Premature Ovarian Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Premature Ovarian Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Premature Ovarian Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule T...
May 2022
39 pages
Primary Ciliary Dyskinesia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Primary Ciliary Dyskinesia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Primary Ciliary Dyskinesia Drugs in Development by Stages, Target, MoA, RoA, Molecule...
May 2022
41 pages
Primary CNS Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Primary CNS Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Primary CNS Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Ke...
May 2022
55 pages
Primary Hyperoxaluria Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Primary Hyperoxaluria Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Primary Hyperoxaluria Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and...
May 2022
44 pages
Primary Hyperoxaluria Type I Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Primary Hyperoxaluria Type I Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Primary Hyperoxaluria Type I Drugs in Development by Stages, Target, MoA, RoA, Mole...
May 2022
38 pages
Primary Mediastinal B-Cell Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Primary Mediastinal B-Cell Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Primary Mediastinal B-Cell Lymphoma Drugs in Development by Stages, Target,...
May 2022
129 pages
Primitive Neuroectodermal Tumor (PNET) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Primitive Neuroectodermal Tumor (PNET) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Primitive Neuroectodermal Tumor (PNET) Drugs in Development by Stages, Ta...
May 2022
43 pages
Proctitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Proctitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Proctitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an...
May 2022
37 pages
